Ignite Creation Date:
2024-05-06 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03354273
Status:
COMPLETED
Last Update Posted:
2023-07-12
First Post:
2017-11-21
Brief Title:
An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz 18F Injection PET MPI in the Detection of Coronary Artery Disease CAD
Sponsor:
GE Healthcare
Organization:
GE Healthcare
Study Overview
Official Title:
A Phase 3 Open-Label Multicentre Study of Flurpiridaz 18F Injection for Positron Emission Tomography PET Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 3 prospective open-label international multicentre study of Flurpiridaz 18F Injection for PET MPI in patients referred for ICA because of suspected CAD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2017-005011-14 | EUDRACT_NUMBER | None | None |